Plasma S100A12 Levels and Peripheral Arterial Disease in End-Stage Renal Disease
Nephron Extra · 21.12.2011 · 1 (1) · 242-250
DOI: 10.1159/000335198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephron Extra, online erschienen am 21.12.2011. Verfasst von Yayoi Shiotsu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Nephrology, Kyoto Prefectural University of Medicine, Kyoto. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
S100A12 is an endogenous ligand of the receptor for advanced glycation end products (RAGE). Plasma S100A12 levels are high in end-stage renal disease (ESRD) patients undergoing maintenance hemodialysis (HD). Peripheral arterial disease (PAD) is common in HD patients and is associated with increased cardiovascular morbidity and mortality rates in this population. To date, however, no study has specifically assessed the relationship between plasma S100A12 and PAD in HD patients.
Methods
We conducted a cross-sectional study of 152 HD patients in our affiliated hospital. We investigated PAD history and patient characteristics and quantified plasma S100A12 levels in all participants.
Results
HD patients with PAD (n = 26; 21.9 [13.6–33.4] ng/ml) showed significantly higher plasma S100A12 levels than HD patients without PAD (n = 126; 11.8 [7.5–17.6]ng/ml; p < 0.001). In multivariate logistic regression analysis, the plasma S100A12 level (odds ratio [OR] 5.71; 95% confidence interval [CI] 1.29–25.3; p = 0.022) was identified as an independent factor associated with PAD prevalence. Another factor associated with PAD prevalence was the ankle-brachial index (OR 0.54; 95% CI 0.40–0.74; p < 0.001).
Conclusion
These results suggest that plasma S100A12 levels are strongly associated with PAD prevalence in ESRD patients undergoing HD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology and Nephrology, Kyoto Prefectural University of Medicine, Kyoto.
Zitieren
APA
Shiotsu, Y., Mori, Y., Hatta, T., Maki, N., Iida, K., Matsuoka, E., Kado, H., Ishida, R., Kishimoto, N., Tamagaki, K., Nishimura, M., Iwamoto, N., Ono, T., Matsubara, H., & Kosaki, A. (2011). Plasma S100A12 Levels and Peripheral Arterial Disease in End-Stage Renal Disease. Nephron Extra, 1(1), 242-250. https://doi.org/10.1159/000335198
Vancouver
Shiotsu Y, Mori Y, Hatta T, Maki N, Iida K, Matsuoka E, et al. Plasma S100A12 Levels and Peripheral Arterial Disease in End-Stage Renal Disease. Nephron Extra. 2011;1(1):242-250. doi:10.1159/000335198
BibTeX
@article{Shiotsu2011,
author = {Shiotsu, Yayoi and Mori, Yasukiyo and Hatta, Tsuguru and Maki, Noboru and Iida, Kumiko and Matsuoka, Eiko and Kado, Hiroshi and Ishida, Ryo and Kishimoto, Noriko and Tamagaki, Keiichi and Nishimura, Masato and Iwamoto, Noriyuki and Ono, Toshihiko and Matsubara, Hiroaki and Kosaki, Atsushi},
title = {Plasma S100A12 Levels and Peripheral Arterial Disease in End-Stage Renal Disease},
journal = {Nephron Extra},
year = {2011},
volume = {1},
number = {1},
pages = {242--250},
doi = {10.1159/000335198}
}
EUVIMED